Table 3.
Distribution of lymphatic invasion density (LID [nLI/mm2]), peritumoral lymphatic vascular density (P-LVD), and intratumoral lymphatic vascular density (I-LVD) according to clinicopathologic parameters in cases with gastric carcinoma
| Variables |
Mean ± SD (Min.-Max.) |
||
|---|---|---|---|
| LID | P-LVD | I-LVD | |
|
Histological type | |||
| NOS/tubular/papillary |
0.06 ± 0.16 (0–0.8) |
12.8 ± 2.7 (7.2–15.7) |
6.9 ± 4.4 (1–24.3) |
| Mucinous/poorly cohesive |
0.11 ± 0.13 (0–0.8) |
13.8 ± 5.4 (5.9–21.6) |
6.9 ± 2.6 (3.5–10) |
|
Differentiation | |||
| Well/moderate |
0.01 ± 0.01 (0–0.03) |
10.2 ± 2.7 (7.2–15.7) |
5.2 ± 2.1 (1–8.7) |
| Poorly/signet ring cell |
0.10 ± 0.18 (0–0.88) |
14.5 ± 6.2 (5.7–32) |
6.9 ± 2.6 (3.5–10.2) |
|
pN | |||
|
N0 |
0.001 ± 0.003 (0–0.03) |
8.1 ± 1.7 (5.9–11.7) |
3.5 ± 1.5 (1–5.5) |
| N1 |
0.02 ± 0.01 (0–0.04) |
8.6 ± 1.9 (5.7–11) |
4.8 ± 1.9 (3–8.7) |
| N2 |
0.03 ± 0.03 (0–0.02) |
12..6 ± 2.5 (9–17.5) |
6.8 ± 1.9 (3.5–9.3) |
| N3 |
0.18 ± 0.2(0–0.9) |
19.1 ± 5.3 (13.7–32) |
10.6 ± 4.4 (6–24.3) |
|
pT |
0.001 ± 0.003 (0–0.03) |
8.1 ± 1.7 (5.9–11.7) |
3.5 ± 1.5 (1–5.5) |
| T1 |
0.0 ± 0.0 (0–0) |
7.9 ± 1.1 (7.2–8.7) |
3.9 ± 0.6 (3.4–4.3) |
| T2 |
0.0 ± 0.01 (0–0.01) |
10.8 ± 7.2 (5.7–16) |
6.4 ± 3.2 (4.1–8.7) |
| T3 |
0.04 ± 0.05 (0–0.27) |
11.8 ± 4.1 (5.9–22.1) |
5.9 ± 2.8 (1–11.3) |
| T4 |
0.16 ± 0.3 (0–0.88) |
19.1 ± 5.3 (13.7–32) |
9.6 ± 5.2 (4.3–24.3) |
|
TNM stage | |||
| I |
0.0 ± 0.0 (0–0) |
7.7 ± 0.9 (7.2–8.7) |
2.9 ± 1.7 (1–4.3) |
| II |
0.01 ± 0.02 (0.0–0.05) |
9.5 ± 2.9 (5.7–16) |
4.6 ± 1.9 (1.1–8.7) |
| III |
0.13 ± 0.2 (0.01–0.88) |
16.2 ± 5.6 (9–32) |
9 ± 4.2 (7.9–11.5) |
| IV |
- |
- |
- |
| Total | 0.07 ± 0.15 (0–0.88) | 13.1 ± 5.7 (5.7–32) | 6.9 ± 3.9 (1–24.3) |